acute kidney injury 2013
DESCRIPTION
Resident level lecture on AKITRANSCRIPT
acute renal failure…from basics to the latest advances
Joel M. Topf, MDClinical Nephrologist
http://pbfluids.com
the housemoment
Dr. Haas invented the first dialysis machine designed for humans and in 1928 he treated 6 patients.
Dr. Haas invented the first dialysis machine designed for humans and in 1928 he treated 6 patients.
All of them died.
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
Dr. Haas
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
Dr. Haas0 for 22
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
In 1945, a 67-year-old woman in uremic coma presented to Dr Kolff.
Dr. Haas0 for 22
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine from a washing machine, juice cans and sausage casings.
In 1943 he dialyzed his first patient, a young man with acute nephritis.
In 1945, a 67-year-old woman in uremic coma presented to Dr Kolff.
Dr. Haas
Regained consciousness after 11 hours of hemodialysis.
0 for 22
0
20
40
60
80
Mo
rtality (%
)
75
45
Sepsis Other Causes
Mortality by Etiology
Commonly quoted mortality of 70% is for dialysis requiring ICU patients
For hospital acquired ARF: 20%
Am J Med 2005 118, 827-832
Patients with primary diagnosis of AKI have higher mortality when they are:
admitted on week-ends
admitted to smaller hospitals
James et al. Weekend Hospital Admission, Acute Kidney Injury, and Mortality. Journal of the American Society of Nephrology (2010) vol. 21 (5) pp. 845-851
ICU associated AKI is characterized by a d e l a y b e t w e e n a d m i s s i o n a n d d e v e l o p m e n t o f acute renal injury
R isk
I njury
F ailure
L oss of function
E nd-Stage Renal disease
rifle criteria for stratifying arf
R isk
Increase in Cr of 1.5-2.0 X baseline or urine output < 0.5 mL/kg/hr for more than 6 hours.
I njury
F ailure
L oss of function
E nd-Stage Renal disease
R isk: Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs
I njury
increase in Cr 2-3 X baseline (loss of 50% of GFR) or urine output < 0.5 mL/kg/hr for more than 12 hours.
F ailure
L oss of function
E nd-Stage Renal disease
R isk: Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs
I njury: Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs
F ailure increase in Cr rises > 3X baseline Cr (loss of 75% of GFR) or an increase in serum creatinine greater than 4 mg/dL, or urine output < 0.3 mL/kg/hr for more than 24 hours or
anuria for more than 12 hours.
L oss of function
E nd-Stage Renal disease
R isk: Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs
I njury: Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs
F ailure: Inc Cr > 200% or > 4 mg/dL or U.O. < 0.3 mL/kg/hr > 24 hrs or anuria for more than 12 hours
L oss of function persistent renal failure (i.e. need for dialysis) for more than 4
weeks.
E nd-Stage Renal disease
R isk: Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs
I njury: Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs
F ailure: Inc Cr > 200% or > 4 mg/dL or U.O. < 0.3 mL/kg/hr > 24 hrs or anuria for more than 12 hours
L oss of function: Need for dialysis for more than 4 weeks
E nd-Stage Renal disease persistent renal failure (i.e. need for dialysis) for more than 3
months.
R isk: Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs
I njury: Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs
F ailure: Inc Cr > 200% or > 4 mg/dL or U.O. < 0.3 mL/kg/hr > 24 hrs or anuria for more than 12 hours
L oss of function: Need for dialysis for more than 4 weeks
E nd-Stage Renal disease : Need for dialysis for more than 3 months
nice criteria. do they work?
20,126 consecutive admissions to a university hospital Excluded kids Kidney transplant and
dialysis patients Patients admitted for <
24 hours Using RIFLE:
Risk 9.1% Injury 5.2% Failure 3.7%
Uchino S, Bellomo R, Goldsmith D. Crit Care Med 2006 Vol 34 1913-1917.
nice criteria. do they work?
20,126 consecutive admissions to a university hospital Excluded kids Kidney transplant and
dialysis patients Patients admitted for <
24 hours Using RIFLE:
Risk 9.1% Injury 5.2% Failure 3.7%
No Renal failure82%
Failure4%
Injury5%
Risk9%
Uchino S, Bellomo R, Goldsmith D. Crit Care Med 2006 Vol 34 1913-1917.
Hos
pita
l Mor
talit
y
Hos
pita
l Mor
talit
y
>3x
BL
Cr
Cr >
4
Hos
pita
l Mor
talit
y
nice criteria. do they work in the icu?
University of Pittsburgh has 7 ICUs
5,383 patients Excluded dialysis
Subsequent admissions
Frequency of acute Kidney failure: No AKD 1,766
Risk 670
Injury 1,436
Failure 1,511Hoste E, Clermont G, Kersten A. Crit Care 2006 Vol 310
nice criteria. do they work in the icu?
University of Pittsburgh has 7 ICUs
5,383 patients Excluded dialysis
Subsequent admissions
Frequency of acute Kidney failure: No AKD 1,766
Risk 670
Injury 1,436
Failure 1,511
No Renal failure33%
Failure28%
Injury27%
Risk12%
Hoste E, Clermont G, Kersten A. Crit Care 2006 Vol 310
No AKI Risk Injury Failure0
5
10
15
20
25
30
RRTLOSICU LOSMortality
No AKI Risk Injury Failure0
5
10
15
20
25
30
RRTLOSICU LOSMortality
No AKI Risk Injury Failure0
5
10
15
20
25
30
RRTLOSICU LOSMortality
AKIN criteria
refinement of RIFLE criteria smaller change in Cr 0.3 time constraint of 48 hours for the diagnosis of
AKI anyone requiring dialysis is stage 3 AKI
RIFLE v AKIN
RIFLERIFLE
R Cr increased by 50-100%
I Cr increased by 100-200%
F Cr increased by more than 200% or Cr > 4
L Need for dialysis for > 4 weeks
E Need for dialysis for > 3 months
RIFLE v AKIN
RIFLERIFLE
R Cr increased by 50-100%
I Cr increased by 100-200%
F Cr increased by more than 200% or Cr > 4
L
E
RIFLE v AKIN
RIFLERIFLE AKINAKIN
R Cr increased by 50-100% 1 Cr increased by 0.3 or
50-100%
I Cr increased by 100-200% 2 Cr increased by
100-200%
F Cr increased by more than 200% or Cr > 4 3 Cr increased by more
than 200%, Cr > 4, or renal replacement therapyL
Cr increased by more than 200%, Cr > 4, or renal replacement therapy
E
AKIN vs RIFLE120,123 critically ill patients in 57 ICUs in New Zealand and Australia
AKIN vs RIFLE120,123 critically ill patients in 57 ICUs in New Zealand and Australia
64%
16%
14%6%
RIFLE
63%18%
10%9%
AKIN
NoneRisk / 1Injury / 2Failure / 3
AKIN vs RIFLE120,123 critically ill patients in 57 ICUs in New Zealand and Australia
64%
16%
14%6%
RIFLE
63%18%
10%9%
AKIN
NoneRisk / 1Injury / 2Failure / 3
2.24
3.95
5.13
2.45
4.23
5.22
Risk / 1 Injury / 2Failure / 3
mortality odds ratio vs no AKI
oliguria: sensitive or specific?
oliguria is a biomarker of ARF
Used in the definition of RIFLE and AKIN
How good is it at predicting AKICreatinine
ICU patients and tracked hourly urine outputs
oliguria: <0.5 ml/kg/hr
primary outcome: how predictive was oliguria for subsequent AKI as defined by creatinine
239 patients, 723 days, 23 cases of hospital acquired AKI
duration of oliguria AKI the next day No AKI next day
None 5 443
≥1 hour 18 257
≥2 hours 15 194
≥3 hours 13 125
≥4 hours 12 95
≥5 hours 7 75
≥6 hours 5 50
≥12 hours 4 9
duration of oliguria AKI the next day No AKI next day
None 5 443
≥1 hour 18 257
≥2 hours 15 194
≥3 hours 13 125
≥4 hours 12 95
≥5 hours 7 75
≥6 hours 5 50
≥12 hours 4 9
duration of oliguria AKI the next day No AKI next day
None 5 443
≥1 hour 18 257
≥2 hours 15 194
≥3 hours 13 125
≥4 hours 12 95
≥5 hours 7 75
≥6 hours 5 50
≥12 hours 4 9
duration of oliguria AKI the next day No AKI next day
None 5 443
≥1 hour 18 257
≥2 hours 15 194
≥3 hours 13 125
≥4 hours 12 95
≥5 hours 7 75
≥6 hours 5 50
≥12 hours 4 9
ICU associated AKI is characterized by a d e l a y b e t w e e n a d m i s s i o n a n d d e v e l o p m e n t o f acute renal injury
4"days"
1"day"
N=29,269
N=29,269
AKI 1,738 (5.7%)
N=29,269
AKI 1,738 (5.7%)
T h i s d e l a y i n t h e development of AKI is an opportunity.
T h i s d e l a y i n t h e development of AKI is an opportunity.
Often AKI is the result of a second hit. Don’t hit your patient.
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
etiologies of arf
Seventy percent have concurrent oliguria
< 400 mL/day
< 0.5 mL/kg/hr in children
< 1 mL/kg/hr in infants
Complicates 5-7% of hospitalizations
Community acquired49.7%
Hospital acquired50.3%
Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8.Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6.
Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8.Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6.
Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
hospital acquired acute renal failure
Sepsis7%
Other2%
CHF4%
Unknown3%
Other7%
Obstruction2%
Hypotension11%
Volume Contraction21%
Post-Op15%
Contrast11%
Medication16%
hospital acquired acute renal failure
differentiation of prerenal from intrinsic renal disease
Excreted Na
Excreted NaFiltered Na
Excreted NaFiltered Na
Fractional excretion of sodium:
Excreted Na = Urine Na x Urine Volume
Calculating the Numerator
Calculating the Denominator
Calculating the Denominator
Filtered Na = Serum Na x GFR
Calculating the Denominator
GFR = Urine Cr x Urine Volume Serum Cr
Filtered Na = Serum Na x GFR
Calculating the Denominator
GFR = Urine Cr x Urine Volume Serum Cr
Filtered Na = Serum Na x GFR
Filtered Na = Serum Na x UrCr x UrVol Serum Cr
Excreted NaFiltered Na
FENa =
Excreted NaFiltered Na
FENa =
FENa =
Excreted NaFiltered Na
FENa =
Urine Na x Urine VolumeFENa =
Excreted NaFiltered Na
FENa =
Urine Na x Urine VolumeSerum Na x UrCr x Urine Volume Serum Cr
FENa =
Excreted NaFiltered Na
FENa =
Urine Na x Urine VolumeSerum Na x UrCr x Urine Volume Serum Cr
FENa =
Excreted NaFiltered Na
FENa =
Urine Na x Urine VolumeSerum Na x UrCr x Urine Volume Serum Cr
FENa =
Urine NaSerum Na x UrCr Serum Cr
FENa =
Excreted NaFiltered Na
FENa =
Urine Na x Urine VolumeSerum Na x UrCr x Urine Volume Serum Cr
FENa =
Urine NaSerum Na x UrCr Serum Cr
FENa =
Urine Na x Serum CrSerum Na x UrCr
FENa =
FENa the easy way
FENa the easy way
FENa is a small number 0.1% to 3%
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
Sr Na
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na Sr Cr
Sr Na
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na Sr Cr
Sr Na
Sr Cr
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
Ur Na Sr Cr
Sr Na
Sr Cr
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
Ur Na Sr Cr
Sr Na
Sr Cr x Ur Na
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
Ur Na Ur Cr
Sr Cr
Sr Na
Sr Cr x Ur Na
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Sr Na
Ur Na Ur Cr
Sr Cr
Sr Na
Sr Cr x Ur Na
x Ur CrFENa =
FENa the easy way
FENa is a small number 0.1% to 3% So the calculation will be 0.001-0.03 prior to
converting to percent by X 100 So make the fraction small by putting the small
numbers over the big numbers
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
serum Na x GFR x minutes in a day
urinary Na excretion
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
140 x 0.1 x 1440
180
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
20160
180
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
0.8%
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
0.8%
So does ATN cause the tubules to fail to reabsorb the 99%?
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium
0.8%
So does ATN cause the tubules to fail to reabsorb the 99%?
NO
false positive FeNa
Contrast nephropathy Acute glomerulonephritis ATN with heart failure ATN with burns ATN with cirrhosis
Contrast nephropathy Acute glomerulonephritis ATN with heart failure ATN with burns ATN with cirrhosis
Low FeNa not pre-renal
Contrast nephropathy Acute glomerulonephritis ATN with heart failure ATN with burns ATN with cirrhosis
Low FeNa not pre-renal
Contrast nephropathy Acute glomerulonephritis ATN with heart failure ATN with burns ATN with cirrhosis
Low FeNa not pre-renal
these are cases of ATN where the tubules effectively hold on to sodium
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium but now the GFR is 30 not 100
The fena reflects the behavior of the tubules that are undamaged. Tubules affected by ischemia have a GFR of zero.
serum Na x GFR x minutes in a day
urinary Na excretion
Why is the feNa high in ATN
Normally tubules reabsorb 98-99% of the filtered sodium but now the GFR is 30 not 100
The fena reflects the behavior of the tubules that are undamaged. Tubules affected by ischemia have a GFR of zero.
Why is the feNa high in ATN
140 x 0.03 x 1440
180
Normally tubules reabsorb 98-99% of the filtered sodium but now the GFR is 30 not 100
The fena reflects the behavior of the tubules that are undamaged. Tubules affected by ischemia have a GFR of zero.
Why is the feNa high in ATN
6048
180
Normally tubules reabsorb 98-99% of the filtered sodium but now the GFR is 30 not 100
The fena reflects the behavior of the tubules that are undamaged. Tubules affected by ischemia have a GFR of zero.
Why is the feNa high in ATN
2.9%
Normally tubules reabsorb 98-99% of the filtered sodium but now the GFR is 30 not 100
The fena reflects the behavior of the tubules that are undamaged. Tubules affected by ischemia have a GFR of zero.
Acute renal success
GFR is normally 100 mL/min
Total plasma volume is only 3 liters
without massive fluid reabsorption, 30 minutes to filter all the plasma
Acute renal success
GFR is normally 100 mL/min
Total plasma volume is only 3 liters
without massive fluid reabsorption, 30 minutes to filter all the plasma
Acute renal success
GFR is normally 100 mL/min
Total plasma volume is only 3 liters
without massive fluid reabsorption, 30 minutes to filter all the plasma
Acute renal success
GFR is normally 100 mL/min
Total plasma volume is only 3 liters
without massive fluid reabsorption, 30 minutes to filter all the plasma
Tubuloglomerular feedback
Kaplan, Kohn. American J Nephrol, 1992; 12: 49-54.
fractional excretion of urea
Based on the physiologic increase in urea reabsorption with pre-renal azotemia
Normal FE Urea is 50-65% in well hydrated individuals
In prerenal azotemia this falls below 35% Not affected by diuretics
Sr Na
Sr Cr x Ur Na
x Ur CrFENa =
Kaplan, Kohn. American J Nephrol, 1992; 12: 49-54.
fractional excretion of urea
Based on the physiologic increase in urea reabsorption with pre-renal azotemia
Normal FE Urea is 50-65% in well hydrated individuals
In prerenal azotemia this falls below 35% Not affected by diuretics
Sr Urea
Sr Cr x Ur Urea
x Ur CrFEurea =
Kaplan, Kohn. American J Nephrol, 1992; 12: 49-54.
fractional excretion of urea
Based on the physiologic increase in urea reabsorption with pre-renal azotemia
Normal FE Urea is 50-65% in well hydrated individuals
In prerenal azotemia this falls below 35% Not affected by diuretics
Sr Urea
Sr Cr x Ur Urea
x Ur CrFEurea =
Carvounis, Sabeeha, Nisar, Et al. Kidney Int, 2002 Vol 62. p 2223-2229
FEurea in the differential diagnosis of atn
102 patients with ARF
Gold standard was consultants full analysis and retrospective analysis of response to treatment.
Divided the cases into: ATN
Prerenal without diuretic
Prerenal treated with diuretics
0
25
50
75
100
Sensitivity (%
)
92
50
91 90
Pre-Renal, No diuretics Pre-Renal, Diuretics
FENaFEUrea
FENa
FEUrea
outcomes
Nephrology Dialysis Transplantation 23 2235-41, 2008Clin J Am Soc Nephrol 3: 881-886, 2008
outcomes
Nephrology Dialysis Transplantation 23 2235-41, 2008Clin J Am Soc Nephrol 3: 881-886, 2008
outcomes
Nephrology Dialysis Transplantation 23 2235-41, 2008Clin J Am Soc Nephrol 3: 881-886, 2008
Acute kidney injury as a cause of CKD
3,679 diabetic veterans baseline creatinine 1.1, average age 61 primary outcome: development of CKD 4 secondary outcome: all-cause mortality
1,822 hospitalized 530 developed AKI at least once
88% AKIN 1
12% AKIN 2, 3
39,805 Kaiser Permanente Hospitalized 1996-2003 all had pre-hospitalization GFR <45 among those who developed ARF (50%
increase in Cr and dialysis) 26% died in the hospital among survivors:
GFR 30-44 42% required permanent dialysis within a month of discharge
GFR 15-29 63% required permanent dialysis within a month of discharge
26%
5%
20%
49%
ARF in hospital
Death in Hosp Died after d/c Alive, No dialysis ESRD
5%4%
90%
2%
No ARF in hospital
34.7%
27.6%28.4%
45.2%
14.4%
77.0%
Death during Hospital
ESRD after D/C
GFR 30-44 GFR 15-29 GFR <15
even the lucky ones, not so lucky
Survivors of ARF, not dialysis dependent
No ARF
dial
ysis
-free
sur
viva
l
used to be...No dialysis. No foul.
Acute renal failure is a risk factor for progression of CKDAcute renal failure is a risk factor for progression of CKD
therapy
Internist management
Patient empowerment
Renal replacement therapy
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
Internist management
Monitor I’s and O’s, daily weights
Frequent labs BMP, phosphorous,
albumin, U/A
Consult nephrology
Avoid hypotension
Dose adjust for renal failure
Follow-up after d/c for high risk of CKD
Avoid Iodinated contrast Aminoglycosides ACEi/ARB
Thoughtful fluid management
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
risk factors for AKI
CKD
Age >75
Peripheral vascular disease
Heart failure
Liver disease
Diabetes
Nephrotoxins NSAIDs
Aminoglycoseide
Hypotension Hypovolemia
Cardiac disease
Iatrogenic
Sepsis
Patient empowerment
talk to patients about what to do if they become acutely ill
increase fluid intake
decrease diuretics
monitor blood pressure
renal replacement therapy
Dialysate
1405.8
10817
76
7.8
1452
11035
0
0
Conventional Dialysis: combination of diffusive and convective Clearance
1405.8
10817
67
3.8
BloodUltra-filtrate
Dialysate
1405.8
10817
76
7.8
1452
11035
0
0
Conventional Dialysis: combination of diffusive and convective Clearance
1405.8
10817
67
3.8
BloodUltra-filtrate
1365.8
10817
67
3.8
Isolated Ultrafiltration: CHF SolutionsMinimal clearance
1365.8
10817
67
3.8
1365.8
10817
67
3.8
Isolated Ultrafiltration: CHF SolutionsMinimal clearance
1365.8
10817
67
3.8
1365.8
10817
67
3.8
80 mmol KIsolated Ultrafiltration: CHF SolutionsMinimal clearance
1365.8
10817
67
3.8
1365.8
10817
67
3.8
80 mmol K5.8 mmol/L
Isolated Ultrafiltration: CHF SolutionsMinimal clearance
1365.8
10817
67
3.8
1365.8
10817
67
3.8
80 mmol K5.8 mmol/L
= 13.8 litersIsolated Ultrafiltration: CHF SolutionsMinimal clearance
Ultrafilter 3+ liters/hour
Replace all ultrafiltratewith sterile fluid at idealplasma concentrations
1365.8
10817
67
3.8
140 2
10830
0
0
CVVHConvective clearance
Ultrafilter 3+ liters/hour
Replace all ultrafiltratewith sterile fluid at idealplasma concentrations
1365.8
10817
67
3.8
140 4
10830
0
0
CVVHConvective clearance
Post-filter replacement fluid
CVVHConvective clearance
Pre-filter replacement fluid
CVVHConvective clearance
CVVHDFConvective and Diffusive
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
Low dose
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
High dose
Low dose
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
High dose
Low dose
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
High dose
Low dose
high dose dialysissu
rviva
l
Severity of illness (CCARF Score)
High dose
Low dose
Ronco’s landmark dialysis dose study
425 patients with dialysis dependent acute renal failure were randomized to one of three doses of CVVH
20 mL/kg/hr of effluent
35 mL/kg/hr
45 mL/kg/hr
20 mL/kg/hr
35 mL/kg/hr
45 mL/kg/hr
Ronco C, Bellomo R, Hormea P, Et al. Lancet 2000; 355: 26-30.
Ronco 425 CVVH 20/h vs. 35-45 ml/kg/h*
Bouman 106 CVVH 20ml/kg/h* vs. 48 ml/kg/h
Schiffl 160 Alternate day vs. daily hemodialysis
Saudan 206 CVVH 25 ml/kg/h vs. CVVHDF 42 ml/kg/h
Total (fixed effects)
Total (random effects)
1 10Odds ratio
Study n treatment groups
*For purposes of analysis the two high-dose arms in Ronco were combined, as were the two low-dose arms in Bouman. If these groups are removed the odds ratio is unchanged (1.94; P <0.001).
Kellum J. Nature Clin Practice Nephrol 2007 3: 128-9.
Ronco 425 CVVH 20/h vs. 35-45 ml/kg/h*
Bouman 106 CVVH 20ml/kg/h* vs. 48 ml/kg/h
Schiffl 160 Alternate day vs. daily hemodialysis
Saudan 206 CVVH 25 ml/kg/h vs. CVVHDF 42 ml/kg/h
Total (fixed effects)
Total (random effects)
1 10Odds ratio
Study n treatment groups
*For purposes of analysis the two high-dose arms in Ronco were combined, as were the two low-dose arms in Bouman. If these groups are removed the odds ratio is unchanged (1.94; P <0.001).
Kellum J. Nature Clin Practice Nephrol 2007 3: 128-9.
ATN trial
US trial Prospective randomized, multi-center trial
27 institutions primarily veterans hospitals
Dose finding study, modality agnostic Conventional
dialysis SLED
CVVH CVVHD
CVVHDF
interventions
endpoint
Primary Endpoint: All-cause mortality at day 60.
Secondary endpoints: In-hospital death Recovery of renal function (CrCl>20)
defined as complete if Cr was <0.5 over the baseline
Duration of renal replacement therapy Dialysis free at 60 days Duration of ICU stay Return to previous home at day 60
results
results
563 enrolled in standard care561 randomized to intensive therapy
60% sepsis
80% vented
Apache II score 26 predicted mortality 55%
BUN at initiation of RRT 65
half in the MICU half in the SICU
This report currently should be viewed as the definitive study defining dialysis dosing in critically ill patients with AKI
H. David Hume
…the patient dies from multi-organ failure while in exquisite electrolyte
& fluid balance.
Fluid balance?
Fluid balance?
Patients stratified by net fluid gain from admission to initiation of CRT
Fluid in – fluid outICU admit weight X 100
longer ICU stay
higher mortality
more multi-organ dysfunction
more likely to be intubated
more inotropes
more sepsis
higher PRISM score
More fluid. More sick.
Worse fluid overload severity remained independently associated with mortality (OR, 1.03; 95% CI, 1.01-1.05). The relationship was satisfactorily linear and the OR suggests a
3% increase in mortality for each 1% increase in degree of fluid overload at CRRT initiation.
80 kg adult Is and Os: 2,400 mL in (100 mL/hr) and
1,600 mL of urine (67 mL/hr) Positive balance of 800 mL. If after 3 days the
patient becomes oliguric with 200 mL of urine output for two days (2,200 mL positive per day) before initiating CRT.
That patient would be up 6,800 mL or 8% of bodyweight
24% increase in mortality compared to someone with matched ins and outs
observational data from SOAP study of ICU care in Europe
198 ICUs 24 countries 147 patients 1120 had AKI ARF defined as a Cr >3.5 or urine output <
500 mL
Moreover, this would suggest that prevention or management of fluid overload is evolving as a primary trigger/indicator for e x t r a - c o r p o re a l fl u i d remova l , and th is may be independent of dose delivery or solute clearance.
Critical Care 2008, 12:169
summary
Prognosis is grim We have two validated, consensus definitions
R isk I njury F ailure L oss of function E srd
Outpatient and inpatient acquired ARF differ in etiology
Hospital acquired disease is your fault
AKIN Stage 1 Stage 2 Stage 3
summary
FE of Urea is a validated way to separate pre-renal from AKI even in the presence of diuretics
Use of high dose dialysis regardless of methodology offers no survival benefit
Do not fluid overload your patient Dopamine doesn’t work
Acute kidney injury is not a specialist’s emergency; it is seen commonly in acute medicine and, as such, it is essential that all physicians have the confidence and ski l ls to identify and manage it.
Done